Login / Signup

Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab.

Theresa BurkardEnriqueta Vallejo-YagüeKim LauperAxel FinckhThomas HügleAndrea M Burden
Published in: RMD open (2023)
Our longitudinal investigation suggests that BMI increase may not lead to changes in DAS28-esr in patients receiving infliximab, despite the weight-adapted dose. Yet, there may be a decrease in erosions with increasing weight non-limited to obese patients.
Keyphrases